The Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma

被引：0
|
作者：
Yang, Qiwei [1 ]
Falahati, Ali [2 ]
Khosh, Azad [2 ]
Omran, Mervat [1 ]
Bariani, Maria V. [1 ]
Al-Hendy, Ayman [1 ]
机构：
[1] Univ Chicago, Chicago, IL USA
[2] Yazd Univ, Yazd, Iran
来源：
REPRODUCTIVE SCIENCES | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-131
引用
收藏
页码：97A / 97A
页数：1
相关论文
共 50 条
  • [41] EFFECTS OF BROMODOMAIN AND EXTRA-TERMINAL DOMAIN INHIBITION ON CYSTIC FIBROSIS LUNG INFLAMMATION
    Chen, K.
    Kolls, J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 271 - 271
  • [42] How Might Bromodomain and Extra-Terminal (BET) Inhibitors Operate in Cardiovascular Disease?
    Schooling, C. Mary
    Zhao, Jie V.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (02) : 107 - 111
  • [43] Therapeutic Potential of Bromodomain and Extra-Terminal Domain Inhibitors for Synovial Sarcoma Cells
    Kotani, Yuki
    Imura, Yoshinori
    Nakai, Sho
    Chijimatsu, Ryota
    Takami, Haruna
    Inoue, Akitomo
    Mae, Hirokazu
    Takenaka, Satoshi
    Outani, Hidetatsu
    Okada, Seiji
    CANCERS, 2024, 16 (06)
  • [44] Fragment-Based Drug Discovery in the Bromodomain and Extra-Terminal Domain Family
    Radwan, Mostafa
    Serya, Rabah
    ARCHIV DER PHARMAZIE, 2017, 350 (08)
  • [45] Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)
    Bian, Benjamin
    Juiz, Natalia Anahi
    Gayet, Odile
    Bigonnet, Martin
    Brandone, Nicolas
    Roques, Julie
    Cros, Jerome
    Wang, Nenghui
    Dusetti, Nelson
    Iovanna, Juan
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [46] Trichostatin A downregulates bromodomain and extra-terminal proteins to suppress osimertinib resistant non-small cell lung carcinoma
    Meng, Yuting
    Qian, Xixi
    Zhao, Li
    Li, Nan
    Wu, Shengjie
    Chen, Baoan
    Sun, Tong
    Wang, Xuerong
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [47] Trichostatin A downregulates bromodomain and extra-terminal proteins to suppress osimertinib resistant non-small cell lung carcinoma
    Yuting Meng
    Xixi Qian
    Li Zhao
    Nan Li
    Shengjie Wu
    Baoan Chen
    Tong Sun
    Xuerong Wang
    Cancer Cell International, 21
  • [48] Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
    Alqahtani, Ali
    Choucair, Khalil
    Ashraf, Mushtaq
    Hammouda, Danae M.
    Alloghbi, Abduraham
    Khan, Talal
    Senzer, Neil
    Nemunaitis, John
    FUTURE SCIENCE OA, 2019, 5 (03):
  • [49] Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma
    Tseng, Hsin-Yi
    Dreyer, Jan
    Al Emran, Abdullah
    Gunatilake, Dilini
    Pirozyan, Mehdi
    Cullinane, Carleen
    Dutton-Regester, Ken
    Rizos, Helen
    Hayward, Nicholas K.
    McArthur, Grant
    Hersey, Peter
    Tiffen, Jessamy
    Gallagher, Stuart
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (08) : 2176 - 2189
  • [50] Development of a Novel Positron Emission Tomography (PET) Radiotracer Targeting Bromodomain and Extra-Terminal Domain (BET) Family Proteins
    Bai, Ping
    Lan, Yu
    Wang, Hao
    Chen, Zude
    Fiedler, Stephanie
    Striar, Robin
    Lu, Xiaoxia
    Wang, Changning
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
12345